MedTrace Logo

Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy

NCT01837394 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-11-06

No results posted yet for this study

Summary

In this study, we wish to investigate the effect of ultrasound (US) -guided block of the saphenous nerve (SN) and the posterior branch of the obturator nerve (ONP) on postoperative pain and the use of opioids (morphine-like pain medicine) in the first 24 hours following ambulatory knee arthroscopy.

We wish to investigate the analgesic effect of these two blocks compared to placebo (injection of local anesthetic with known pain blocking properties compared with injection of a saline solution), when used as a supplement to conventional oral analgesics.

We hypothesize that patients receiving the active treatment may experience less pain during the first 24 hours after their operation than patients receiving the placebo treatment, and possibly require less opioid analgesics, experience less opioid related side effects and have a higher function level in this period than patients receiving the placebo treatment.

Conditions

  • Postoperative Pain
  • Postoperative Nausea and Vomiting
  • Postoperative Function Level

Interventions

PROCEDURE

Block of the SN and ONP

7.5 ml of Ropivacaine 7.5 mg/ml injected at each site

PROCEDURE

Placebo block

7.5 ml of isotonic saline solution 154 mmol/l injected at each site

DRUG

Paracetamol

DRUG

Morphine

5 mg as needed

DRUG

Ondansetron

4 mg i.v. as needed in the PACU

DRUG

Metoclopramide

10 mg tablet as needed in the postoperative period after discharge from the PACU

Sponsors & Collaborators

  • Jens Borglum Neimann

    lead OTHER

Principal Investigators

  • Bo Westergaard, MD · Department of Anesthesiology, Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-06-30
Completion
2013-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01837394 on ClinicalTrials.gov